Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-25-008756
Filing Date
2025-03-21
Accepted
2025-03-21 16:35:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 vxrt20250321_424b5.htm 424B5 410968
2 logo.jpg GRAPHIC 16636
  Complete submission text file 0001437749-25-008756.txt   435326
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270671 | Film No.: 25761041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)